Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Case Reports|January 25, 2021
Iatrogenic esophageal and tracheal perforation with tracheoesophageal fistula following emergency intubationAkram Alkrekshi, Hazim Bukamur
The Oncologist|March 3, 2021
Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis C Virus InfectionAkram Alkrekshi, Ila Tamaskar
Clinical Lymphoma, Myeloma & Leukemia|July 31, 2021
Risk of Non-Hodgkin's Lymphoma in HCV Patients in the United States Between 2013 and 2020: A Population-Based StudyAkram Alkrekshi, Ahmad Kassem, Changsu Park, et al.
Cureus|September 17, 2019
Recurrent Cutaneous Squamous Cell Carcinoma with Direct Invasion of the Pleura: A Case ReportAkram Alkrekshi, Moneeb Mustafa, Hala Abdul-Al, et al.
BMJ Case Reports|November 2, 2022
Humoral hypercalcaemia of malignancy associated with a gigantic cutaneous squamous cell carcinomaDina Elantably, Abdul Rahman Al Armashi, Faris Hammad, et al.
Cellular Signalling|July 5, 2021
A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistanceAkram Alkrekshi, Wei Wang, Priyanka Shailendra Rana, et al.
Biomedicines|September 28, 2021
The Role of WAVE2 Signaling in CancerPriyanka Shailendra Rana, Akram Alkrekshi, Wei Wang, et al.
Southern Medical Journal|September 4, 2021
Immune Checkpoint Inhibitor-Related Pulmonary Toxicity: A Comprehensive Review, Part IIHazim Bukamur, Akram Alkrekshi, Heather Katz, et al.
Southern Medical Journal|November 3, 2020
Immune Checkpoint Inhibitor-Related Pulmonary Toxicity: Focus on NivolumabHazim Bukamur, Heather Katz, Mohamed Alsharedi, et al.
Bone Marrow Transplantation|August 21, 2023
CD19-targeted chimeric antigen receptor T-cell therapy in patients with concurrent B-cell Non-Hodgkin lymphoma and rheumatic autoimmune diseases: a propensity score matching studyJiasheng Wang, Akram Alkrekshi, Srilatha Dasari, et al.
Pageof 2